NCT05935748 2025-11-12
Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)
NiKang Therapeutics, Inc.
Phase 2 Terminated
NiKang Therapeutics, Inc.
NanOlogy, LLC
Celldex Therapeutics
Cedars-Sinai Medical Center
Sir Mortimer B. Davis - Jewish General Hospital